Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schulzer

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 5, 2002
Rett syndrome: investigation of nine patients, including PET scanHenry G Dunn, A Jon Stoessl, Helena H Ho, et al.
Archives of Internal Medicine|May 10, 2006
Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopneaNajib T Ayas, J Mark FitzGerald, John A Fleetham, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2014
In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriersAndre C Felicio, Katherine Dinelle, Pankaj A Agarwal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 31, 2018
Habitual exercisers versus sedentary subjects with Parkinson's Disease: Multimodal PET and fMRI studyMatthew A Sacheli, Danielle K Murray, Nasim Vafai, et al.
Annals of Neurology|January 20, 2011
Age-specific progression of nigrostriatal dysfunction in Parkinson's diseaseRaúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, et al.
Brain : a Journal of Neurology|August 6, 2005
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensationJohn R Adams, Hinke van Netten, Michael Schulzer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 5, 2019
Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's diseaseMatthew A Sacheli, Jason L Neva, Bimal Lakhani, et al.
The Lancet. Neurology|March 25, 2017
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studiesDaryl J Wile, Pankaj A Agarwal, Michael Schulzer, et al.
The Lancet. Neurology|February 20, 2018
The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET studyShu-Ying Liu, Daryl J Wile, Jessie Fanglu Fu, et al.
Cell|December 4, 2003
EMSY links the BRCA2 pathway to sporadic breast and ovarian cancerLuke Hughes-Davies, David Huntsman, Margarida Ruas, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 5, 2002
Rett syndrome: investigation of nine patients, including PET scanHenry G Dunn, A Jon Stoessl, Helena H Ho, et al.
Archives of Internal Medicine|May 10, 2006
Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopneaNajib T Ayas, J Mark FitzGerald, John A Fleetham, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2014
In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriersAndre C Felicio, Katherine Dinelle, Pankaj A Agarwal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 31, 2018
Habitual exercisers versus sedentary subjects with Parkinson's Disease: Multimodal PET and fMRI studyMatthew A Sacheli, Danielle K Murray, Nasim Vafai, et al.
Annals of Neurology|January 20, 2011
Age-specific progression of nigrostriatal dysfunction in Parkinson's diseaseRaúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, et al.
Brain : a Journal of Neurology|August 6, 2005
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensationJohn R Adams, Hinke van Netten, Michael Schulzer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 5, 2019
Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's diseaseMatthew A Sacheli, Jason L Neva, Bimal Lakhani, et al.
The Lancet. Neurology|March 25, 2017
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studiesDaryl J Wile, Pankaj A Agarwal, Michael Schulzer, et al.
The Lancet. Neurology|February 20, 2018
The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET studyShu-Ying Liu, Daryl J Wile, Jessie Fanglu Fu, et al.
Cell|December 4, 2003
EMSY links the BRCA2 pathway to sporadic breast and ovarian cancerLuke Hughes-Davies, David Huntsman, Margarida Ruas, et al.
Pageof 8